Westinghouse Plan of Reorganization Confirmed
Westinghouse Electric Company today obtained approval from the U.S. Bankruptcy Court for the Southern District of New York (the Court) of the company’s plan of reorganization (the Plan).
The Court’s approval of the Plan is a significant milestone in the company’s strategic restructuring, which involves its previously announced sale to Brookfield Business Partners L.P. (NYSE:BBU) (TSX:BBU.UN). The sale is expected to close in the third quarter of 2018, subject to customary closing conditions including, among others, regulatory approvals.
The Plan was overwhelmingly supported by Westinghouse’s creditor constituencies.
“Confirmation of our plan of reorganization is one of the final steps in the completion of our strategic restructuring,” said José Emeterio Gutiérrez, Westinghouse president and chief executive officer. “Our customers, employees, suppliers, vendors, and other important constituencies overwhelmingly supported our plan of reorganization. We are on track to fulfill our promise to emerge from this strategic restructuring process as a stronger business partner while retaining our primary focus on safety.”
Weil, Gotshal & Manges LLP is Westinghouse’s legal counsel, AlixPartners LLP is acting as Westinghouse’s Chief Transformation Officer and restructuring advisor, and PJT Partners is the investment banker to Westinghouse.
Westinghouse Electric Company
Courtney Boone, +1 724-816-9408
Vice President, Global Communications
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
NJ-CELGENE19.7.2019 20:01:04 CEST | Press release
FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease
JANSSEN19.7.2019 15:07:11 CEST | Press release
Abiraterone Acetate Included in World Health Organisation’s Essential Medicines List for the Treatment of Metastatic Castration-Resistant Prostate Cancer
CA-GILEAD-SCIENCES19.7.2019 14:32:09 CEST | Press release
Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis
SCHLUMBERGER-LIMITED19.7.2019 13:02:04 CEST | Press release
Schlumberger Announces Second-Quarter 2019 Results
TX-SCHLUMBERGER-LIMITED19.7.2019 12:48:04 CEST | Press release
Schlumberger Appoints Olivier Le Peuch as CEO
WA-FLUKE-CORPORATION19.7.2019 12:02:10 CEST | Press release
Fluke Corporation Acquires Industrial Reliability Leader PRÜFTECHNIK
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom